Whitehawk Therapeutics (WHWK)

• Market cap: $107M
• 1 day: -14.29%
• 5 days: 14%
• 1 month: 20%
• 3 months: 23.24%
• 6 months: 47.1%
• Year to date: -27.39%
• 1 year: 8.57%
• 5 years: -88.22%
• 10 years: -96.1%
• Sector: Healthcare
• Industry: Biotechnology

About: Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Employees: 21